Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

86 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Predictive value of Follicular Lymphoma International Prognostic Index (FLIPI) in patients with follicular lymphoma at first progression.
Montoto S, López-Guillermo A, Altés A, Perea G, Ferrer A, Camós M, Villela L, Bosch F, Esteve J, Cervantes F, Bladé J, Nomdedeu B, Campo E, Sierra J, Montserrat E. Montoto S, et al. Among authors: villela l. Ann Oncol. 2004 Oct;15(10):1484-9. doi: 10.1093/annonc/mdh406. Ann Oncol. 2004. PMID: 15367408 Free article.
Thalidomide in multiple myeloma: lack of response of soft-tissue plasmacytomas.
Bladé J, Perales M, Rosiñol L, Tuset M, Montoto S, Esteve J, Cobo F, Villela L, Rafel M, Nomdedeu B, Montserrat E. Bladé J, et al. Among authors: villela l. Br J Haematol. 2001 May;113(2):422-4. doi: 10.1046/j.1365-2141.2001.02765.x. Br J Haematol. 2001. PMID: 11380408 Free article.
Ibrutinib plus Bendamustine and Rituximab in Untreated Mantle-Cell Lymphoma.
Wang ML, Jurczak W, Jerkeman M, Trotman J, Zinzani PL, Belada D, Boccomini C, Flinn IW, Giri P, Goy A, Hamlin PA, Hermine O, Hernández-Rivas JÁ, Hong X, Kim SJ, Lewis D, Mishima Y, Özcan M, Perini GF, Pocock C, Song Y, Spurgeon SE, Storring JM, Walewski J, Zhu J, Qin R, Henninger T, Deshpande S, Howes A, Le Gouill S, Dreyling M; SHINE Investigators. Wang ML, et al. N Engl J Med. 2022 Jun 30;386(26):2482-2494. doi: 10.1056/NEJMoa2201817. Epub 2022 Jun 3. N Engl J Med. 2022. PMID: 35657079 Clinical Trial.
A Multi-Institutional Validation of the Prognostic Value of the Neutrophil-to-Lymphocyte Ratio in Patients With Diffuse Large B-Cell Lymphoma: A Study From The Latin American Group of Lymphoproliferative Disorders (GELL).
Beltrán BE, Villela L, Torres MA, Otero V, Fiad L, Peña C, Cabrera ME, León P, Idrobo H, Castro DA, Paredes S, Perdomo I, Abello V, Rojas C, Ramirez-Ibargüen A, Candelaria M, Pérez-Jacobo F, Montaño-Figueroa E, Best C, Goméz-De Leon A, Gómez-Almaguer D, Ruiz-Argüelles G, Hernández-Hernández J, Malpica L, Sotomayor EM, Castillo JJ; Latin American Group of Lymphoproliferative Disorders (Grupo de Estudio Latinoamericano de Linfoproliferativos [GELL]). Beltrán BE, et al. Among authors: villela l. Clin Lymphoma Myeloma Leuk. 2020 Oct;20(10):637-646. doi: 10.1016/j.clml.2020.04.016. Epub 2020 May 4. Clin Lymphoma Myeloma Leuk. 2020. PMID: 32513598
An international, multicenter, retrospective study on the positive impact of cutaneous involvement on the clinical outcome of adult T-cell leukemia/lymphoma.
Malpica L, Castro D, Enriquez DJ, Oviedo-Pecho R, Peña C, Idrobo H, Fiad L, Prates M, Valcarcel B, Paredes A, Sánchez G, Moisés C, Castillo JJ, Villela L, Ramos JC, Biglione M, Beltran BE; Grupo de Estudio Latinoamericano de Linfoproliferativos (GELL). Malpica L, et al. Among authors: villela l. Leuk Lymphoma. 2022 Feb;63(2):315-325. doi: 10.1080/10428194.2021.1984455. Epub 2021 Sep 29. Leuk Lymphoma. 2022. PMID: 34585997
86 results